📊 Market Breakdown
TSLA is trading at $329.65 and is caught between major zones — the Golden Fib Zone ($365–$385) above and the Equilibrium ($294) below.
Trend: Price recently broke out of a descending trendline but is still inside a bigger channel.
Pattern Watch: There’s a potential cup & handle forming. If confirmed, this could be the fuel that launches us toward the $365–$385 resistance area.
Momentum: MACD is flattening near zero (possible bullish crossover brewing), and RSI at 56 gives us room to push higher before overbought territory.
🛒 CALLS (Bullish Scenario)
Buy Zones:
🎯 Aggressive Entry: Bounce from $320–$325 support
✅ Confirmation Entry: Daily close above $340 with strong volume
Take Profits:
1️⃣ $365 – First target at the start of Golden Fib Zone
2️⃣ $385 – Fib Zone top and key resistance
3️⃣ $488 – Long-term premium/supply zone
Stop-Loss: $315 (just below recent support)
Why This Works: A breakout above $340 also breaks the handle of the cup, unlocking room to run toward $365+.
🛑 PUTS (Bearish Scenario)
Sell Zones:
🚨 Rejects $340 resistance with heavy selling
📉 Breakdown and daily close under $315
Take Profits:
1️⃣ $294 – Equilibrium
2️⃣ $250 – Key psychological level
3️⃣ $215–$220 – Discount/Demand Zone
Stop-Loss: $330 (above rejection point)
Why This Works: A failed breakout with a close under $315 breaks short-term bullish structure, opening the door for a drop back toward $294 equilibrium.
🔍 Technical Highlights
Cup & Handle Potential: Neckline around $340; break = bullish continuation.
EMA 200 ($219.82): Still far below, showing this is more of a swing/mid-term momentum play.
Volume: Recent spikes suggest institutions are active at these levels.
Macro Watch: TSLA moves with tech sentiment; keep an eye on NASDAQ trend.
⏳ Option Expiration Strategy:
1 Week: For quick bounce or rejection plays at $340
2 Weeks: Breakout targeting $365
3 Weeks: Full push toward $385–$488 supply zone
TSLA is trading at $329.65 and is caught between major zones — the Golden Fib Zone ($365–$385) above and the Equilibrium ($294) below.
Trend: Price recently broke out of a descending trendline but is still inside a bigger channel.
Pattern Watch: There’s a potential cup & handle forming. If confirmed, this could be the fuel that launches us toward the $365–$385 resistance area.
Momentum: MACD is flattening near zero (possible bullish crossover brewing), and RSI at 56 gives us room to push higher before overbought territory.
🛒 CALLS (Bullish Scenario)
Buy Zones:
🎯 Aggressive Entry: Bounce from $320–$325 support
✅ Confirmation Entry: Daily close above $340 with strong volume
Take Profits:
1️⃣ $365 – First target at the start of Golden Fib Zone
2️⃣ $385 – Fib Zone top and key resistance
3️⃣ $488 – Long-term premium/supply zone
Stop-Loss: $315 (just below recent support)
Why This Works: A breakout above $340 also breaks the handle of the cup, unlocking room to run toward $365+.
🛑 PUTS (Bearish Scenario)
Sell Zones:
🚨 Rejects $340 resistance with heavy selling
📉 Breakdown and daily close under $315
Take Profits:
1️⃣ $294 – Equilibrium
2️⃣ $250 – Key psychological level
3️⃣ $215–$220 – Discount/Demand Zone
Stop-Loss: $330 (above rejection point)
Why This Works: A failed breakout with a close under $315 breaks short-term bullish structure, opening the door for a drop back toward $294 equilibrium.
🔍 Technical Highlights
Cup & Handle Potential: Neckline around $340; break = bullish continuation.
EMA 200 ($219.82): Still far below, showing this is more of a swing/mid-term momentum play.
Volume: Recent spikes suggest institutions are active at these levels.
Macro Watch: TSLA moves with tech sentiment; keep an eye on NASDAQ trend.
⏳ Option Expiration Strategy:
1 Week: For quick bounce or rejection plays at $340
2 Weeks: Breakout targeting $365
3 Weeks: Full push toward $385–$488 supply zone
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.